Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kjell Ove Fossan"'
Autor:
Silje Skrede, Jon Andsnes Berg, Kjell Ove Fossan, Christoffer Bartz-Johannessen, Else-Marie Løberg, Rune Andreas Kroken, Erik Johnsen
Publikováno v:
Emerging Trends in Drugs, Addictions, and Health, Vol 1, Iss , Pp 100024- (2021)
Background: The prevalence of new psychoactive substances (NPS) in acute psychotic patients has not been investigated systematically. We applied a highly sensitive and specific mass spectrometry method for detection of NPS as well as traditional drug
Externí odkaz:
https://doaj.org/article/ea8f2bcdbf724d3a9a212c407b7bbc60
Autor:
Oystein Eikrem, Spiros Kotopoulis, Mihaela Popa, Mireia Mayoral Safont, Kjell Ove Fossan, Sabine Leh, Lea Landolt, Janka Babickova, Oddrun Anita Gudbrandsen, Odd Helge Gilja, Bettina Riedel, Jan Schjøtt, Emmet McCormack, Hans-Peter Marti
Publikováno v:
Pharmaceutics, Vol 13, Iss 12, p 2038 (2021)
The use of ultrasound and microbubble-enhanced drug delivery, commonly referred to as sonoporation, has reached numerous clinical trials and has shown favourable results. Nevertheless, the microbubbles and acoustic path also pass through healthy tiss
Externí odkaz:
https://doaj.org/article/b9a2d595e6bf4a8b8445de81c7fdee61
Autor:
Sabine Leh, Odd Helge Gilja, Mireia Mayoral Safont, Oddrun Anita Gudbrandsen, Øystein Solberg Eikrem, Bettina Riedel, Mihaela-Lucia Popa, Lea Landolt, Janka Bábíčková, Spiros Kotopoulis, Jan Schjøtt, Kjell Ove Fossan, Emmet McCormack, Hans-Peter Marti
Publikováno v:
Pharmaceutics
Pharmaceutics; Volume 13; Issue 12; Pages: 2038
Pharmaceutics, Vol 13, Iss 2038, p 2038 (2021)
Pharmaceutics; Volume 13; Issue 12; Pages: 2038
Pharmaceutics, Vol 13, Iss 2038, p 2038 (2021)
The use of ultrasound and microbubble-enhanced drug delivery, commonly referred to as sonoporation, has reached numerous clinical trials and has shown favourable results. Nevertheless, the microbubbles and acoustic path also pass through healthy tiss
Autor:
Rune A. Kroken, Jon Andsnes Berg, Else-Marie Løberg, Kjell Ove Fossan, Erik Johnsen, Christoffer Bartz-Johannessen, Silje Skrede
Publikováno v:
Emerging Trends in Drugs, Addictions, and Health, Vol 1, Iss, Pp 100024-(2021)
Emerging Trends in Drugs, Addictions, and Health
Emerging Trends in Drugs, Addictions, and Health
Background The prevalence of new psychoactive substances (NPS) in acute psychotic patients has not been investigated systematically. We applied a highly sensitive and specific mass spectrometry method for detection of NPS as well as traditional drugs
Autor:
Kjell Ove Fossan, Jan Schjøtt, Tormod Karlsen Bjånes, Kjersti Carstensen, Silje Skrede, Trond Trætteberg Serkland, Bettina Riedel, Jon Andsnes Berg
Publikováno v:
Therapeutic Drug Monitoring. 41:249-250
Publikováno v:
Toxicology Mechanisms and Methods
Aim: Short-time models (STM) to study the cardiotoxicity (acute or chronic) of doxorubicin in rats are of interest to assess protective interventions and pathways. STM promotes more ethical animal treatment with less stress, and at a lower cost compa
Publikováno v:
Substance Abuse and Rehabilitation
Jon Andsnes Berg,1 Jan Schjøtt,1,2 Kjell O Fossan,1 Bettina Riedel1,21Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, 2Faculty of Medicine and Dentistry, Department of Clinical Science, Universit
Autor:
Kari Merete Ersland, Silje Skrede, Vidar M. Steen, Rolf K. Berge, I.H. Duus, Ismael González-García, Kjell Ove Fossan, Johan Fernø
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 25(6)
Treatment with second-generation antipsychotic agents such as olanzapine frequently results in metabolic adverse effects, e.g. hyperphagia, weight gain and dyslipidaemia in patients of both genders. The molecular mechanisms underlying metabolic adver
Publikováno v:
Clinical Therapeutics. 35(8):e13-e14
Publikováno v:
BMC Pharmacology & Toxicology
BMC Pharmacology and Toxicology
BMC Pharmacology and Toxicology
Aim: Chemotherapy with doxorubicin is limited by cardiotoxicity. Free radical generation and mitochondrial dysfunction are thought to contribute to doxorubicin-induced cardiac failure. In this study we wanted to investigate if opening of mitochondria